These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

257 related items for PubMed ID: 27700109

  • 21. Development of fully amorphous dispersions of a low T(g) drug via co-spray drying with hydrophilic polymers.
    Zhao M, Barker SA, Belton PS, McGregor C, Craig DQ.
    Eur J Pharm Biopharm; 2012 Nov; 82(3):572-9. PubMed ID: 22922419
    [Abstract] [Full Text] [Related]

  • 22. Effects of polymer type and storage relative humidity on the kinetics of felodipine crystallization from amorphous solid dispersions.
    Rumondor AC, Stanford LA, Taylor LS.
    Pharm Res; 2009 Dec; 26(12):2599-606. PubMed ID: 19806435
    [Abstract] [Full Text] [Related]

  • 23. Investigation into Intermolecular Interactions and Phase Behavior of Binary and Ternary Amorphous Solid Dispersions of Ketoconazole.
    Sarpal K, Tower CW, Munson EJ.
    Mol Pharm; 2020 Mar 02; 17(3):787-801. PubMed ID: 31860316
    [Abstract] [Full Text] [Related]

  • 24. Improved Release of Celecoxib from High Drug Loading Amorphous Solid Dispersions Formulated with Polyacrylic Acid and Cellulose Derivatives.
    Xie T, Taylor LS.
    Mol Pharm; 2016 Mar 07; 13(3):873-84. PubMed ID: 26791934
    [Abstract] [Full Text] [Related]

  • 25. Ability of different polymers to inhibit the crystallization of amorphous felodipine in the presence of moisture.
    Konno H, Taylor LS.
    Pharm Res; 2008 Apr 07; 25(4):969-78. PubMed ID: 17520180
    [Abstract] [Full Text] [Related]

  • 26. Mid-infrared spectroscopy as a polymer selection tool for formulating amorphous solid dispersions.
    Wegiel LA, Mauer LJ, Edgar KJ, Taylor LS.
    J Pharm Pharmacol; 2014 Feb 07; 66(2):244-55. PubMed ID: 24433425
    [Abstract] [Full Text] [Related]

  • 27. Dissolution Performance of High Drug Loading Celecoxib Amorphous Solid Dispersions Formulated with Polymer Combinations.
    Xie T, Taylor LS.
    Pharm Res; 2016 Mar 07; 33(3):739-50. PubMed ID: 26563205
    [Abstract] [Full Text] [Related]

  • 28. Investigation and correlation of drug polymer miscibility and molecular interactions by various approaches for the preparation of amorphous solid dispersions.
    Meng F, Trivino A, Prasad D, Chauhan H.
    Eur J Pharm Sci; 2015 Apr 25; 71():12-24. PubMed ID: 25686597
    [Abstract] [Full Text] [Related]

  • 29. Solvent-shift strategy to identify suitable polymers to inhibit humidity-induced solid-state crystallization of lacidipine amorphous solid dispersions.
    Sun M, Wu C, Fu Q, Di D, Kuang X, Wang C, He Z, Wang J, Sun J.
    Int J Pharm; 2016 Apr 30; 503(1-2):238-46. PubMed ID: 26869398
    [Abstract] [Full Text] [Related]

  • 30. Physical stability of API/polymer-blend amorphous solid dispersions.
    Lehmkemper K, Kyeremateng SO, Bartels M, Degenhardt M, Sadowski G.
    Eur J Pharm Biopharm; 2018 Mar 30; 124():147-157. PubMed ID: 29269154
    [Abstract] [Full Text] [Related]

  • 31. Understanding the Effect of Nucleation in Amorphous Solid Dispersions through Time-Temperature Transformation.
    Lalge R, Kumar NSK, Suryanarayanan R.
    Mol Pharm; 2023 Aug 07; 20(8):4196-4209. PubMed ID: 37358932
    [Abstract] [Full Text] [Related]

  • 32. Hydroxypropyl cellulose stabilizes amorphous solid dispersions of the poorly water soluble drug felodipine.
    Sarode AL, Malekar SA, Cote C, Worthen DR.
    Carbohydr Polym; 2014 Nov 04; 112():512-9. PubMed ID: 25129775
    [Abstract] [Full Text] [Related]

  • 33. Complementarity of mDSC, DMA, and DRS Techniques in the Study of Tg and Sub-Tg Transitions in Amorphous Solids: PVPVA, Indomethacin, and Amorphous Solid Dispersions Based on Indomethacin/PVPVA.
    Thayumanasundaram S, Venkatesan TR, Ousset A, Van Hollebeke K, Aerts L, Wübbenhorst M, Van den Mooter G.
    Mol Pharm; 2022 Jul 04; 19(7):2299-2315. PubMed ID: 35674392
    [Abstract] [Full Text] [Related]

  • 34. Polymer incorporation method affects the physical stability of amorphous indomethacin in aqueous suspension.
    Surwase SA, Itkonen L, Aaltonen J, Saville D, Rades T, Peltonen L, Strachan CJ.
    Eur J Pharm Biopharm; 2015 Oct 04; 96():32-43. PubMed ID: 26092472
    [Abstract] [Full Text] [Related]

  • 35. Amorphous stabilization and dissolution enhancement of amorphous ternary solid dispersions: combination of polymers showing drug-polymer interaction for synergistic effects.
    Prasad D, Chauhan H, Atef E.
    J Pharm Sci; 2014 Nov 04; 103(11):3511-3523. PubMed ID: 25196860
    [Abstract] [Full Text] [Related]

  • 36. Investigation and correlation of physical stability, dissolution behaviour and interaction parameter of amorphous solid dispersions of telmisartan: a drug development perspective.
    Dukeck R, Sieger P, Karmwar P.
    Eur J Pharm Sci; 2013 Jul 16; 49(4):723-31. PubMed ID: 23684913
    [Abstract] [Full Text] [Related]

  • 37. Construction of drug-polymer thermodynamic phase diagrams using Flory-Huggins interaction theory: identifying the relevance of temperature and drug weight fraction to phase separation within solid dispersions.
    Tian Y, Booth J, Meehan E, Jones DS, Li S, Andrews GP.
    Mol Pharm; 2013 Jan 07; 10(1):236-48. PubMed ID: 23110477
    [Abstract] [Full Text] [Related]

  • 38. Insights into the Dissolution Mechanism of Ritonavir-Copovidone Amorphous Solid Dispersions: Importance of Congruent Release for Enhanced Performance.
    Indulkar AS, Lou X, Zhang GGZ, Taylor LS.
    Mol Pharm; 2019 Mar 04; 16(3):1327-1339. PubMed ID: 30669846
    [Abstract] [Full Text] [Related]

  • 39. Evaluate the ability of PVP to inhibit crystallization of amorphous solid dispersions by density functional theory and experimental verify.
    Wang B, Wang D, Zhao S, Huang X, Zhang J, Lv Y, Liu X, Lv G, Ma X.
    Eur J Pharm Sci; 2017 Jan 01; 96():45-52. PubMed ID: 27568852
    [Abstract] [Full Text] [Related]

  • 40. Synergistic effect of polymers in stabilizing amorphous pretomanid through high drug loaded amorphous solid dispersion.
    Juneja M, Mehtre K, Saini V, Singh R, Amate P, Kashyap M, Sangamwar AT.
    Drug Deliv Transl Res; 2024 Jun 05. PubMed ID: 38837117
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.